BioNTech’s (BNTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Friday morning, Benzinga reports. HC Wainwright currently has a $113.00 target price on the stock. Other analysts also recently issued research reports about the stock. Canaccord Genuity Group restated a buy rating and set a $171.00 […]
More Stories
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...